Amyloid‐β PET and CSF in an autopsy‐confirmed cohort

OBJECTIVE: Accumulation of amyloid‐β is among the earliest changes in Alzheimer’s disease (AD). Amyloid‐β positron emission tomography (PET) and Aβ (42) in cerebrospinal fluid (CSF) both assess amyloid‐β pathology in‐vivo, but 10–20% of cases show discordant (CSF+/PET− or CSF‐/PET+) results. The neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimand, Juhan, Boon, Baayla D. C., Collij, Lyduine E., Teunissen, Charlotte E., Rozemuller, Annemieke J. M., van Berckel, Bart N. M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664271/
https://www.ncbi.nlm.nih.gov/pubmed/33080124
http://dx.doi.org/10.1002/acn3.51195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664271/
https://www.ncbi.nlm.nih.gov/pubmed/33080124
http://dx.doi.org/10.1002/acn3.51195

Ejemplares similares